← SynDRA
ustekinumab
SynDRA canonical compound SYN0042216 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | TYMS |
|---|
| Mechanism of action | dihydrofolate reductase inhibitor |
|---|
| Indication | malaria |
|---|
| Disease area | infectious disease |
|---|
All known targets
- IL12A
- IL23A
- IL12B
- PDF
- TYMS
Mechanisms of action (all sources)
- IL12B INHIBITOR
- Interleukin-12 inhibitor
- IL12A INHIBITOR
- Interleukin-23 inhibitor
- IL23A INHIBITOR
- dihydrofolate reductase inhibitor
- PDF INHIBITOR
- IL12A ANTIBODY BINDING
- IL12B ANTIBODY BINDING
- IL23A ANTIBODY BINDING
Drug classes
- Dermatologic Agents
- Interleukin-12 Antagonists
- Interleukin-12 Antagonist
- Interleukin-23 Antagonists
- Interleukin-23 Antagonist
ATC classes
- L04A · IMMUNOSUPPRESSANTS
Cross-references
Synonyms
- stelara
- CNTO-1275
- 6,6-Dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine
- WR99210
- WR 99210
- BRN 0629517
- 1,3,5-Triazine-2,4-diamine, 1,6-dihydro-6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-
- WR-99,210
- CHEMBL129788
- BRL 6231
- 1,6-Dihydro-6,6-dimethyl-1-(3-(2,4,5-trichlorophenoxy)-propoxy)-1,3,5-triazine-2 ,4-diamine
- 1-(2',4',5'-Trichlorophenoxypropoxy)-1,2-dihydro-2,2-dimethyl-4,6-diamino-s-triazine
- Stelara (TN)
- Pyzchiva
- Selarsdi
- Ustekinumab-aekn
- Ustekinumab-ttwe
- TT-20
- Stelara
- Stelera
- Uzpruvo
- Wezenla
Look up ustekinumab in the interactive SynDRA portal →